| Identify the pharmacologic options for the management of status epilepticus (SE). |
|
|
|
|
|
|
| Compare potential third-line treatment strategies in refractory status epilepticus (RSE) and patient factors that contribute to therapeutic decision-making. |
|
|
|
|
|
|
| Review guideline recommendations and practice changing literature related to SE and RSE pharmacotherapy. |
|
|
|
|
|
|